Report Content
Chapter 1 Methodology & Scope
1.1 Market definition
1.2 Base estimates & calculations
1.3 Forecast parameters
1.4 COVID-19 impact analysis at global level
1.5 Data validation
1.6 Data Sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Biologics outsourcing industry 360º synopsis, 2018 – 2032
2.1.1 Business trends
2.1.2 Regional trends
2.1.3 Product trends
2.1.4 Service trends
2.1.5 Source trends
2.1.6 Application trends
2.1.7 End-user trends
Chapter 3 Biologics Outsourcing Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2018 - 2032 (USD Million)
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Growing complexity of biologics manufacturing, leading to increased outsourcing services
3.3.1.2 Cost-effectiveness and efficiency offered by CROs and CMOs
3.3.1.3 Technological advantages offered by CROs and CMOs
3.3.1.4 Patent expiry and increasing demand for biologics
3.3.1.5 Increasing investments in advanced manufacturing technologies by CDMOs
3.3.1.6 Increasing regulatory compliance and quality assurance
3.3.2 Industry pitfalls & challenges
3.3.2.1 Varying regulatory requirements across regions
3.3.2.2 Lack of constant innovation to balance technological capabilities against costs
3.3.2.3 Potential for loss of in-house expertise may limit biologics outsourcing
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By service
3.4.3 By source
3.4.4 By application
3.4.5 By end-user
3.5 COVID- 19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Canada
3.6.3 Europe
3.7 Technology landscape
3.8 Industry ecosystem
3.9 Porter's analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
4.1 Introduction
4.1.1 Merck & Co. Inc
4.1.2 AbbVie Inc
4.1.3 Thermo Fischer Scientific, Inc.
4.2 Company matrix analysis, 2022
4.3 Competitive analysis of major market players, 2022
4.4 Competitive positioning matrix, 2022
4.5 Company market share analysis, 2022
4.6 Strategy dashboard, 2022
Chapter 5 Biologics Outsourcing Market, By Product, 2018 - 2032 (USD Million)
5.1 Key trends, by product
5.2 Antibodies
5.2.1 Monoclonal antibodies
5.2.2 Polyclonal antibodies
5.2.3 Antibody drug conjugates
5.3 Vaccines
5.4 Cell and gene therapeutics
5.5 Recombinant proteins
5.6 Blood and blood products
5.7 Other biologics
Chapter 6 Biologics Outsourcing Market, By Service, 2018 - 2032 (USD Million)
6.1 Key trends, by service
6.2 Analytical testing
6.3 Process development
6.4 Cell development
6.5 cGMP manufacturing
6.6 Other services
Chapter 7 Biologics Outsourcing Market, By Source, 2018 - 2032 (USD Million)
7.1 Key trends, by source
7.2 Mammalian
7.2.1 Animals
7.2.2 Human
7.3 Microorganisms
Chapter 8 Biologics Outsourcing Market, By Application, 2018 - 2032 (USD Million)
8.1 Key trends, by application
8.2 Oncology
8.3 Immunological disorders
8.4 Infectious diseases
8.5 Vaccine development
8.6 Cell and gene therapy
8.7 Blood related product development
8.8 Stem cell research
8.9 Other applications
Chapter 9 Biologics Outsourcing Market, By End-user, 2018 - 2032 (USD Million)
9.1 Key trends, by end-user
9.2 Pharmaceutical and biopharmaceutical companies
9.3 Biotechnological companies
Chapter 10 Biologics Outsourcing Market, By Region, 2018 - 2032 (USD Million)
10.1 Key trends, by region
10.2 North America
10.2.1 U.S.
10.2.2 Canada
10.3 Europe
10.3.1 Germany
10.3.2 UK
10.3.3 France
10.3.4 Spain
10.3.5 Italy
10.3.6 Switzerland
10.3.7 Rest of Europe
10.4 Asia Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 Rest of Asia Pacific
10.5 Latin America
10.5.1 Brazil
10.5.2 Mexico
10.5.3 Rest of Latin America
10.6 Middle East & Africa
10.6.1 South Africa
10.6.2 Saudi Arabia
10.6.3 Rest of Middle East & Africa
Chapter 11 Company Profiles
11.1 AbbVie Inc.
11.2 Thermo Fischer Scientific Inc.
11.3 Boehringer Ingelheim International GmbH
11.4 Merck & Co., Inc.
11.5 Lonza Group AG
11.6 Catalent, Inc
11.7 Wacker Chemie AG (Wacker Biotech GmbH Plc.)
11.8 WuXi AppTec Co., Ltd.
11.9 Samsung Biologics Co., Ltd.
11.10 AGC Biologics
11.11 Scorpius BioManufacturing
